These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27495060)

  • 1. rs1495741 as a tag single nucleotide polymorphism of N-acetyltransferase 2 acetylator phenotype associates bladder cancer risk and interacts with smoking: A systematic review and meta-analysis.
    Ma C; Gu L; Yang M; Zhang Z; Zeng S; Song R; Xu C; Sun Y
    Medicine (Baltimore); 2016 Aug; 95(31):e4417. PubMed ID: 27495060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.
    García-Closas M; Hein DW; Silverman D; Malats N; Yeager M; Jacobs K; Doll MA; Figueroa JD; Baris D; Schwenn M; Kogevinas M; Johnson A; Chatterjee N; Moore LE; Moeller T; Real FX; Chanock S; Rothman N
    Pharmacogenet Genomics; 2011 Apr; 21(4):231-6. PubMed ID: 20739907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
    Wu H; Wang X; Zhang L; Mo N; Lv Z
    Clin Genitourin Cancer; 2016 Apr; 14(2):122-9. PubMed ID: 26585839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.
    Hosen MB; Islam J; Salam MA; Islam MF; Hawlader MZ; Kabir Y
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):78-84. PubMed ID: 25376209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.
    Green J; Banks E; Berrington A; Darby S; Deo H; Newton R
    Br J Cancer; 2000 Aug; 83(3):412-7. PubMed ID: 10917561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: An updated meta-analysis based on 54 case-control studies.
    Song Y; Qi X; Liu X
    Gene; 2020 Oct; 757():144924. PubMed ID: 32622992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population.
    Klimčáková L; Habalová V; Sivoňová M; Nagy V; Šalagovič J; Židzik J
    Mol Biol Rep; 2011 Feb; 38(2):1287-93. PubMed ID: 20568013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer.
    Deitz AC; Rothman N; Rebbeck TR; Hayes RB; Chow WH; Zheng W; Hein DW; García-Closas M
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1543-6. PubMed ID: 15342459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
    Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk.
    Zhao H; Lin J; Grossman HB; Hernandez LM; Dinney CP; Wu X
    Int J Cancer; 2007 May; 120(10):2208-13. PubMed ID: 17290402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
    Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese women.
    Hara A; Taira N; Mizoo T; Nishiyama K; Nogami T; Iwamoto T; Motoki T; Shien T; Matsuoka J; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Miyoshi S
    Breast Cancer; 2017 Mar; 24(2):254-262. PubMed ID: 27068825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
    Stern MC; Johnson LR; Bell DA; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis.
    Teleka S; Hindy G; Drake I; Poveda A; Melander O; Liedberg F; Orho-Melander M; Stocks T
    PLoS One; 2020; 15(11):e0241711. PubMed ID: 33237904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group.
    Xu WJ; Wen LP; Jiang XX; Ye LY; Meng FH; Guan S; Qian YJ; Wei JF
    Clin Lab; 2017 Feb; 63(2):287-293. PubMed ID: 28182356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.